Status:
WITHDRAWN
Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Leading House for the Latin American Region (Seed Money Grant SMG 1730)
Conditions:
Borderline Personality Disorder (BPD)
Eligibility:
All Genders
14-18 years
Brief Summary
The link between epigenetic changes as an effect of psychotherapy has been investigated recently. Genes investigated in these studies were brain-derived neurotrophic factor (BDNF), NR3C1, FKBP51, MAOA...
Eligibility Criteria
Inclusion
- adolescents presenting 3 or more criteria for BPD in the Structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) axis II personality disorders (SCID-II)
Exclusion
- difficulties to understand or comply with instructions
- psychotic disorders
- pervasive developmental disorders
- severe somatic or neurological disorders
- severe and persistent substance addiction
- elevated risk for complications related to blood sampling
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04095546
Start Date
April 1 2022
End Date
December 1 2024
Last Update
September 13 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.